| Literature DB >> 35010559 |
Aureliusz Kosendiak1, Magdalena Król2, Milena Ściskalska2, Marta Kepinska2.
Abstract
The ongoing COVID-19 pandemic has significantly limited social contacts, thus contributing to deepening isolation. Therefore, SARS-CoV-2 exerted on humanity not only a physical impact but also a psychological one, often increasing the feeling of stress. The long-term effects of such a state could include the management of depression, so our study aimed to analyze groups of medical students in different periods of the pandemic (at the beginning of the pandemic, after half a year of the pandemic, after one year of the pandemic) in order to assess the impact of this situation on coping with stress. The impact of the pandemic on the development of stress factors such as alcohol consumption and smoking was also studied. The level of physical activity in the context of coping with an uncertain situation was also assessed. The impact of the above-mentioned factors on the behavior of students, including the Mini-COPE questionnaire, AUDIT test, the Fagerström test and the IPAQ questionnaire was analyzed. It has been shown that as the pandemic and the lockdown progressed, patients consumed more often or larger amounts of alcohol, smoked more cigarettes, and levels of physical activity decreased. All these factors may have had some impact on the deterioration of coping with stress among the respondents, which would indicate that the COVID-19 pandemic significantly contributed to an increase in the sense of stress among the students.Entities:
Keywords: COVID-19; alcohol; distress; physical activity; smoking
Mesh:
Year: 2021 PMID: 35010559 PMCID: PMC8744869 DOI: 10.3390/ijerph19010302
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Characteristic of the study group.
| Stage | Stage I | Stage II | Stage III |
|---|---|---|---|
| Sex | 1007/313 | 632/213 | 599/156 |
| Age [years] | 20.97 ± 2.15 | 20.13 ± 1.55 | 20.45 ± 1.87 |
| BMI [kg/m2] | 21.95 ± 4.76 | 21.43 ± 2.92 | 21.89 ± 3.34 |
Legend: X—average; SD—standard deviation.
Association between coping with stress and progression of COVID-19 pandemic.
| Stage | Stage I * | Stage II | Stage III | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Median | X ± SD | Median | X ± SD |
|
| Median | X ± SD |
| |
| Active stress-coping methods | 2.00 | 1.75 ± 0.73 | 2.00 | 2.15 ± 0.76 |
|
| 2.00 | 2.08 ± 0.81 |
|
| Planning | 2.00 | 1.82 ± 0.73 | 2.00 | 2.04 ± 0.80 |
|
| 2.00 | 2.01 ± 0.83 |
|
| Positive re-evaluation | 2.00 | 1.61 ± 0.78 | 1.50 | 1.43 ± 0.86 |
|
| 1.50 | 1.47 ± 0.91 |
|
| Acceptance | 2.00 | 2.01 ± 0.68 | 2.00 | 1.72 ± 0.80 |
|
| 2.00 | 1.67 ± 0.82 |
|
| Sense of humor | 1.00 | 1.02 ± 0.67 | 1.00 | 0.95 ± 0.71 |
|
| 1.00 | 0.92 ± 0.73 |
|
| Turning to religion | 0.50 | 0.86 ± 0.96 | 0.50 | 0.92 ± 1.00 | 0.1720 | - | 0.50 | 0.95 ± 1.02 | - |
| Seeking emotional support | 2.00 | 1.82 ± 0.82 | 2.00 | 1.99 ± 0.90 |
|
| 2.00 | 1.93 ± 0.93 |
|
| Seeking instrumental support | 2.00 | 1.63 ± 0.82 | 2.00 | 1.88 ± 0.93 |
|
| 2.00 | 1.87 ± 0.90 |
|
| Dealing with other things | 2.00 | 1.71 ± 0.71 | 1.50 | 1.56 ± 0.76 |
|
| 1.50 | 1.55 ± 0.78 |
|
| Denial | 2.00 | 1.75 ± 0.73 | 2.00 | 2.15 ± 0.76 |
|
| 2.00 | 2.08 ± 0.81 |
|
| Giving vent to one’s feelings | 2.00 | 1.82 ± 0.73 | 2.00 | 2.04 ± 0.80 | 0.0800 | - | 2.00 | 2.01 ± 0.83 | - |
| Taking in psychopharmaceuticals | 2.00 | 1.61 ± 0.78 | 1.50 | 1.43 ± 0.86 |
|
| 1.50 | 1.47 ± 0.91 |
|
| Doing nothing | 2.00 | 2.01 ± 0.68 | 2.00 | 1.72 ± 0.80 | 0.2490 | - | 2.00 | 1.67 ± 0.82 | - |
| Self-blaming | 1.00 | 1.02 ± 0.67 | 1.00 | 0.95 ± 0.71 |
|
| 1.00 | 0.92 ± 0.73 |
|
Legend: * Stage I—treated as a point of reference for further analysis, Stage I was compared with Stage II and Stage III; X—average; SD—standard deviation; p—significance level; 1—values obtained in the Skillings–Mack test; 2—values obtained in the post-hoc Dunn’s test. Data were obtained with the Skillings–Mack test and the Dunn’s test. p-values marked with bold indicate statistically significant differences between the groups.
Association between alcohol drinking pattern and progression of COVID-19 pandemic.
| Stage | Stage I * | Stage II | Stage III | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | χ2 | OR | 95% CI |
| Bonferroni Correction | N | % | χ2 | OR | 95% CI |
| Bonferroni Correction | |
| <8 points | 772 | 91.36% | 554 | 78.58% | 66.14 | 2.43 | 1.96–3.03 |
| 0.0042 | 470 | 68.71% | 110.88 | 0.25 | 0.19–0.32 |
| 0.0042 |
| 8–15 points | 66 | 7.81% | 133 | 18.87% | 131.00 | 6.84 | 4.82–9.70 |
| 0.0042 | 189 | 27.63% | 296.13 | 0.05 | 0.04–0.08 |
| 0.0042 |
| 16–19 points | 4 | 0.47% | 8 | 1.13% | 10.26 | 6.79 | 2.01–22.87 |
| 0.0042 | 11 | 1.61% | 37.88 | 0.05 | 0.02–0.18 |
| 0.0042 |
| >20 points | 3 | 0.36% | 10 | 1.42% | 17.67 | 11.31 | 3.07–41.66 |
| 0.0042 | 14 | 2.05% | 56.56 | 0.03 | 0.01–0.11 |
| 0.0042 |
Legend: * Stage I—treated as a point of reference for further analysis, Stage I was compared with Stage II and Stage III; χ2—“χ2 score” in chi square test; OR—odds ratio; 95% CI—confidence interval; p—significance level. Data were obtained with the chi square test. p-values marked with bold indicate statistically significant differences between the groups.
Association between smoking pattern and progression of COVID-19 pandemic.
| Stage | Stage I * | Stage II | Stage III | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | χ2 | OR | 95% CI |
| Bonferroni Correction | N | % | χ2 | OR | 95% CI |
| Bonferroni Correction | |
| Non-smoker | 1238 | 93.79% | 774 | 92.69% | 1.60 | 1.22 | 0.90–1.67 | 0.2066 | 0.0042 | 657 | 87.02% | 16.75 | 1.86 | 1.38–2.50 |
| 0.0042 |
| 0–4 points | 82 | 6.21% | 54 | 6.47% | 0.45 | 0.89 | 0.62–1.26 | 0.5024 | 0.0042 | 93 | 12.32% | 28.98 | 2.32 | 1.69–3.16 |
| 0.0042 |
| 5–8 points | 0 | 0% | 6 | 0.72% | 7.71 | – | – | 0.0055 | 0.0042 | 4 | 0.53% | 5.38 | – | – | 0.0204 | 0.0042 |
| 9–11 points | 0 | 0% | 1 | 0.12% | 0.07 | – | – | 0.7854 | 0.0042 | 1 | 0.13% | 0.13 | – | – | 0.7161 | 0.0042 |
Legend: * Stage I—treated as a point of reference for further analysis, Stage I was compared with Stage II and Stage III; χ2—“χ2 score” in chi square test; OR—odds ratio; 95% CI—confidence interval; p—significance level. Data were obtained with the chi square test. p-values marked with bold indicate statistically significant differences between the groups.
Association between physical activity and progression of COVID-19 pandemic.
| Stage | Stage I * | Stage II | Stage III | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % | χ2 | OR | 95% CI |
| Bonferroni Correction | N | % | χ2 | OR | 95% CI |
| Bonferroni Correction | |
| Low | 786 | 59.59 | 631 | 74.68 | 54.56 | 0.49 | 0.40–0.59 |
| 0.0056 | 580 | 76.82 | 63.73 | 0.44 | 0.36–0.54 |
| 0.0056 |
| Medium | 305 | 23.12 | 108 | 12.78 | 36.04 | 0.49 | 0.38–0.62 |
| 0.0056 | 90 | 11.92 | 44.65 | 0.42 | 0.32–0.54 |
| 0.0056 |
| High | 228 | 17.29 | 106 | 12.54 | 8.83 | 0.69 | 0.54–0.88 |
| 0.0056 | 85 | 11.26 | 10.60 | 0.65 | 0.50–0.84 |
| 0.0056 |
Legend: * Stage I—treated as a point of reference for further analysis, Stage I was compared with Stage II and Stage III; χ2—“χ2 score” in chi square test; OR—odds ratio; 95% CI—confidence interval; p—significance level. Data were obtained with the chi square test. p-values marked with bold indicate statistically significant differences between the groups.
Association between physical activity (broken down by exercise intensity (Low, Medium, High) and type of physical activity) and progression of COVID-19 pandemic.
| Part A | ||||||||
|---|---|---|---|---|---|---|---|---|
| Type of Physical Activity | Vigorous | Moderate | Walking | Sedentary Time | ||||
| Together | Q = 114.77, | Q = 44.19, | Q = 28.49, | Q = 61.01, | ||||
| Low | Q = 7.17, | Q = 4.52, | Q = 30.91, | Q = 39.38, | ||||
| Medium | Q = 2.04, | Q = 7.05, | Q = 17.70, | Q = 17.66, | ||||
| High | Q = 0.77, | Q = 0.22, | Q = 5.47, | Q = 11.91, | ||||
|
| ||||||||
|
|
|
|
| |||||
| Stage I—480, Stage II—320 | Stage I—360, Stage II—240 | Stage I—462, Stage II—693 | Stage I—360, Stage II—300 | |||||
|
|
|
|
|
|
| |||
|
|
|
| ||||||
|
|
|
|
|
|
| |||
| 450 | 420 | 0.375 | 720 | 960 | - | 2160 | 2160 | - |
|
|
|
|
|
|
| |||
|
|
|
| ||||||
|
|
|
|
|
|
| |||
| 160 | 160 | - | 490 | 280 |
| 480 | 480 | - |
|
|
|
|
|
|
| |||
|
|
|
| ||||||
|
|
|
|
|
|
| |||
| 396 | 676.5 |
| 462 | 693 |
| 693 | 924 | - |
|
|
|
|
|
|
| |||
|
|
|
| ||||||
|
|
|
|
|
|
| |||
| 360 | 300 |
| 360 | 240 |
| 360 | 300 |
|
|
| ||||||||
|
| ||||||||
|
|
|
|
| |||||
| Stage I—480, Stage III—160 | Stage I—360, Stage III—160 | Stage I—462, Stage III—792 | Stage I—360, Stage III—240 | |||||
|
|
|
|
|
|
| |||
|
|
|
| ||||||
|
|
|
|
|
|
| |||
| 450 | 480 | 0.518 | 720 | 720 | - | 2160 | 1920 | - |
|
|
|
|
|
|
| |||
|
|
|
| ||||||
|
|
|
|
|
|
| |||
| 160 | 90 | - | 490 | 240 |
| 480 | 680 | - |
|
|
|
|
|
|
| |||
|
|
|
| ||||||
|
|
|
|
|
|
| |||
| 396 | 693 |
| 462 | 792 |
| 693 | 1386 | - |
|
|
|
|
|
|
| |||
|
|
|
| ||||||
|
|
|
|
|
|
| |||
| 360 | 240 |
| 360 | 300 |
| 360 | 300 |
|
Legend: p—significance level. In part A data were obtained with the Skillings–Mack test. In parts B and C data were obtained with the post-hoc Dunn’s test. p-values marked with bold indicate statistically significant differences between the groups.